Clinical trials
Carotid Stenosis trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Edinburgh | 2 |
| AdvanceCor GmbH | 1 |
| Archemix Corp. | 1 |
| Brighton and Sussex University Hospitals NHS Trust | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Imperial College Healthcare NHS Trust | 1 |
| Imperial College London | 1 |
| Sanofi | 1 |
| Silk Road Medical | 1 |
| University Hospital, Basel, Switzerland | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carotid Stenosis | 13 |
| Atherosclerosis | 4 |
| Stroke | 4 |
| Carotid Artery Diseases | 3 |
| Amaurosis Fugax | 1 |
| Arteriosclerosis | 1 |
| Hypercholesterolemia | 1 |
| Hyperlipoproteinemia Type II | 1 |
| Intracranial Embolism | 1 |
| Ischemic Attack, Transient | 1 |
Trials
Showing 76 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.